Overview
Luteolin is a naturally occurring flavonoid found in various plants and foods, such as celery, peppers, and chamomile, with emerging evidence supporting its neuroprotective, anti-inflammatory, and antioxidant properties. Pre-clinical studies indicate that luteolin modulates key cellular pathways involved in neurodegenerative diseases, including Alzheimer’s and Parkinson’s, by reducing neuroinflammation, scavenging reactive oxygen species, and protecting mitochondrial function. It promotes mitochondrial biogenesis, enhances ATP production, and induces mitophagy, suggesting a role in maintaining neuronal energy homeostasis and preventing neurodegeneration [1][4][5]. Luteolin has also been investigated as an adjunct in viral infections like COVID-19 due to its immunomodulatory effects [7]. However, concerns exist regarding its endocrine-disrupting potential, with evidence showing it acts as a progesterone antagonist and estrogen agonist, which may pose risks in hormone-sensitive conditions [2]. Despite promising mechanistic data, clinical evidence in humans remains limited, and optimal dosing has not been established through rigorous phase II trials [7][3].
Dosage Guide
Therapeutic Doses
For treatment of specific conditions
Research
Luteolin shows promise in targeting multiple signaling pathways in Alzheimer's and Parkinson's disease models, with strong neuroprotective potential.
Luteolin acts as a progesterone antagonist and potent estrogen agonist, indicating endocrine-disrupting activity.
Highlights the risk of skipping phase II dose-finding trials when developing dietary supplements, which applies to luteolin's clinical development.
Reviews luteolin's anti-inflammatory, antioxidant, and neuroprotective effects in neurodegenerative disease models.
Demonstrates luteolin's modulation of mitochondrial function, including biogenesis, fission/fusion, and OXPHOS improvement.
Reviews potential toxicity of flavonoids, including understudied safety profiles despite widespread supplement use.
Suggests luteolin may support immune response and symptom improvement in COVID-19 as part of nutraceutical combinations.
Discusses lack of robust clinical evidence for many dietary supplements, including flavonoids, for chronic disease prevention.
